Study
A 2025 clinical case report describes a patient developing liver injury after consuming a turmeric and black pepper supplement.
In plain language
A 2025 clinical case report describes a patient developing liver injury after consuming a turmeric and black pepper supplement. The authors stress that clinical safety data for turmeric use remain limited, particularly concerning supplement combinations that enhance bioavailability.
Use the full description to understand the study design, methods, and the limits of the findings.
This case report documents liver injury associated with turmeric and black pepper supplement use. The study details clinical presentation, diagnostic findings, and outcomes, raising awareness about potential hepatotoxicity from concentrated botanical extracts.
Open the original publication for the complete methods, outcomes, and source material.
Published December 2025
Opens at the publisher · external site · may require institutional access
The study provides valuable insights into potential risks associated with turmeric and black pepper supplements but is limited by its design as a case report. It lacks statistical analysis and broader applicability, though it is transparent and discloses conflicts of interest.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 5.0/10 | |
| Bias & Methods | 3.3/10 | |
| Statistical Integrity | 0.0/10 | |
| Transparency | 5.0/10 | |
| Conflict of Interest Disclosure | 10.0/10 | |
| Replication / External Validation | 0.0/10 | |
| Relevance to Seniors | 10.0/10 | |
| Journal Quality | 5.0/10 |
The study highlights an important area for further research, particularly the need for standardized dosing and clinical safety data for dietary supplements.
Build a personalized plan using research-backed studies, conditions, and treatments.